Relative Bioavailability of Sustained-Release (SR) Versus Immediate-Release (IR) Naltrexone (NAL) Formulations in Healthy Obese Volunteers: Implications for Improved Tolerability?

被引：0
|
作者：
Grundy, John
Dunayevich, Fduardo
Guttadauria, Maria
Dunzo, Elise
McKinney, Anthony
Tollefson, Gary
机构：
来源：
OBESITY | 2008年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S217 / S217
页数：1
相关论文
共 14 条
  • [1] RELATIVE BIOAVAILABILITY OF IMMEDIATE-RELEASE AND SUSTAINED-RELEASE HYDRALAZINE FORMULATIONS
    LUDDEN, TM
    ROTENBERG, KS
    LUDDEN, LK
    SHEPHERD, AMM
    WOODWORTH, JR
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (12) : 1026 - 1032
  • [2] RELATIVE BIOAVAILABILITY OF 2 SUSTAINED-RELEASE THEOPHYLLINE FORMULATIONS VERSUS AN IMMEDIATE-RELEASE PREPARATION
    WILLIAMS, RL
    UPTON, RA
    BOSTROM, A
    [J]. JOURNAL OF ASTHMA, 1983, 20 (01) : 27 - 30
  • [3] Study on Relative Bioavailability of Famotidine Sustained-release Tablets in Healthy Volunteers
    吴涛
    曾环想
    陈济民
    潘卫三
    [J]. Journal of Chinese Pharmaceutical Sciences, 1998, (04) : 24 - 29
  • [4] Bioavailability of Oniria®, a Melatonin Prolonged-Release Formulation, Versus Immediate-Release Melatonin in Healthy Volunteers
    Manuel Román Martinez
    Eva García Aguilar
    Samuel Martin Vílchez
    Javier González García
    Sergio Luquero-Bueno
    Paola Camargo-Mamani
    Gina Mejia-Abril
    Laura García-Castro
    Alejandro de Miguel-Cáceres
    Paula Saz-Leal
    Francisco Abad-Santos
    Concepcion Nieto Magro
    Dolores Ochoa Mazarro
    [J]. Drugs in R&D, 2022, 22 : 235 - 243
  • [5] Bioavailability of Oniria®, a Melatonin Prolonged-Release Formulation, Versus Immediate-Release Melatonin in Healthy Volunteers
    Roman Martinez, Manuel
    Garcia Aguilar, Eva
    Martin Vilchez, Samuel
    Gonzalez Garcia, Javier
    Luquero-Bueno, Sergio
    Camargo-Mamani, Paola
    Mejia-Abril, Gina
    Garcia-Castro, Laura
    de Miguel-Caceres, Alejandro
    Saz-Leal, Paula
    Abad-Santos, Francisco
    Nieto Magro, Concepcion
    Ochoa Mazarro, Dolores
    [J]. DRUGS IN R&D, 2022, 22 (03) : 235 - 243
  • [6] A COMPARATIVE BIOAVAILABILITY STUDY ON 2 NEW SUSTAINED-RELEASE FORMULATIONS OF DISODIUMMONOFLUOROPHOSPHATE VERSUS A NONSUSTAINED-RELEASE FORMULATION IN HEALTHY-VOLUNTEERS
    ERLACHER, L
    TEMPL, H
    MAGOMETSCHNIGG, D
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1995, 56 (03) : 196 - 200
  • [7] STEADY-STATE HUMAN PHARMACOKINETICS AND BIOAVAILABILITY OF GUAIFENESIN AND PSEUDOEPHEDRINE IN A SUSTAINED-RELEASE TABLET RELATIVE TO IMMEDIATE-RELEASE LIQUIDS
    WAGNER, DL
    PATEL, VS
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 114 (02) : 171 - 176
  • [8] Bioavailability of three novel oral, sustained-release pellets, relative to an immediate-release tablet containing 500 mg flucytosine: A randomized, open-label, crossover study in healthy volunteers
    Goyal, Vishal
    Krantz, Edrich
    Simon, Francois
    Neven, Anouk
    Eriksson, Johanna
    Saayman, Amaria
    Ibnou Zekri Lassout, Nabila
    Louis, Mathieu
    Robinson, Stephen
    Deshmukh, Abhijit
    Antarkar, Amit
    Ruffell, Carol
    Victor, Sarika
    Chenel, Marylore
    Celebic, Aljosa
    Caplain, Henri
    Gillon, Jean-Yves
    Ribeiro, Isabela
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (03):
  • [9] Pharmacokinetic comparison of sustained- and immediate-release formulations of cilostazol after multiple oral doses in fed healthy male Korean volunteers
    Kim, Yo Han
    Ghim, Jong-Lyul
    Jung, Jin Ah
    Cho, Sang-Heon
    Choe, Sangmin
    Choi, Hee Youn
    Bae, Kyun-Seop
    Lim, Hyeong-Seok
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 3571 - 3577
  • [10] COMPARISON OF ORAL BIOAVAILABILITY AND PK/PD PROPERTIES OF FOUR PROTOTYPE EXTENDED RELEASE (ER) FORMULATIONS WITH IMMEDIATE-RELEASE (IR) TABLETS AFTER SINGLE ORAL ADMINISTRATION OF BI 11634 IN HEALTHY MALE VOLUNTEERS
    Huang, Fenglei
    Koenen-Bergmann, Michael
    Nehmiz, Gerhard
    Breithaupt-Groegler, Kerstin
    Wu, Jing
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1073 - 1073
12